Image IQ: 52-year-old Female with Family History of Breast Cancer

In a study involving over 1,000 women with breast cancer, researchers found that patients with screening-detected breast cancer had a five-year survival rate of 94.4 percent in comparison to 79.6 percent for women with clinically detected breast cancer.

In the third episode of a three-part podcast, Anand Narayan, M.D., Ph.D., and Amy Patel, M.D., discuss the challenges of expanded breast cancer screening amid a backdrop of radiologist shortages and ever-increasing volume on radiology worklists.

New research showed a 96 to 97 percent sensitivity for contrast-enhanced mammography (CEM) with an increased iodine delivery rate facilitating robust contrast enhancement for women with aggressive breast cancer.

In the second episode of a three-part podcast, Anand Narayan, M.D., Ph.D., and Amy Patel, M.D., discuss recent studies published by the Journal of the American Medical Association (JAMA) that suggested moving to more of a risk-adapted model for mammography screening.

High allostatic load, which has been linked to an increased incidence of breast cancer and all-cause mortality, is more than twice as likely to occur in Black and Hispanic women in comparison to White women, according to mammography research presented at the American Society of Clinical Oncology (ASCO) conference.

For women with dense breasts and negative mammograms, contrast-enhanced mammography and abbreviated MRI provided respective cancer detection rates of 19.2 per 1000 exams and 17.4 per 1000 exams, according to new research.